[ Price : $8.95]
FDA approves a UroGen Pharma NDA for Zusduri (mitomycin intravesical solution) for adult patients with recurrent low-grade interme...[ Price : $8.95]
FDA clears a Viz.ai 510(k) for the Viz Subdural Plus, which the company describes as the first and only comprehensive solution for...[ Price : $8.95]
Rutgers University researchers say they have determined that the GlaxoSmithKline anti-seizure drug Lamictal is safe for adults wit...[ Price : $8.95]
Saying that operational consolidations are coming in support services, FDA commissioner Martin Makary asks the staff to view chang...[ Price : $8.95]
FDA grants Sumitomo Pharma America a fast track designation for nuvisertib (TP-3654) and its use in treating patients with interme...[ Price : $8.95]
Current and former CDC employees rally outside the agencys Atlanta headquarters yesterday over Trump Administration-inspired chaos...[ Price : $8.95]
FDA warns Worland, WY-based Amish Origins Management about CGMP violations in its manufacturing of unapproved and misbranded drug ...[ Price : $8.95]
FDA publishes statistics on real-world evidence submissions to CBER and CDER in FY 2024 compared to the previous year.